NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 1.190

-0.8%

Dec 24 12:58 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: HardToFind who wrote (12402)	11/6/2019 8:05:03 PM
From: cacmed	Read Replies (1) of 12873

The prize has nothing to do with this first application. The point of the entire exercise is that he may have engineered a transformative system to attack viruses. This is science. If it works and can be replicated across different targets everything changes! Hope springs eternal. If the produce fails we are done. The money may run out and we go bankrupt and then fight with Diwan if success comes to Theracour afterword. Or, the product works. What we envisioned a few years ago. Then the fight with Diwan is going to be over a lot more money than the proceeds of the first product.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next